Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells (vol 14, 1273507, 2023)

被引：0
|
作者：
Wei, Zhenyu [1 ]
Xu, Jiayu [1 ]
Zhao, Chengkui [1 ,2 ]
Zhang, Min [1 ]
Xu, Nan [2 ,3 ]
Kang, Liqing [2 ,3 ]
Lou, Xiaoyan [2 ,3 ]
Yu, Lei [2 ,3 ]
Feng, Weixing [1 ]
机构：
[1] Harbin Engn Univ, Intelligent Syst Sci & Engn Coll, Harbin, Peoples R China
[2] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China
[3] East China Normal Univ, Sch Chem & Mol Engn, Shanghai, Peoples R China
来源：
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词：
CAR-T cell therapy; cytokine release syndrome (CRS); biomarker; prediction; decision tree;
D O I：
10.3389/fimmu.2024.1379325
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 4 条
  • [1] Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells
    Wei, Zhenyu
    Xu, Jiayu
    Zhao, Chengkui
    Zhang, Min
    Xu, Nan
    Kang, Liqing
    Lou, Xiaoyan
    Yu, Lei
    Feng, Weixing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [2] CAR-T Cell Therapies: An Overview of Clinical Studies Supporting Their Approved Use against Acute Lymphoblastic Leukemia and Large B-Cell Lymphomas
    Ahmad, Aamir
    Uddin, Shahab
    Steinhoff, Martin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) : 1 - 9
  • [3] Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells
    Park, Jae H.
    Romero, F. Andres
    Taur, Ying
    Sadelain, Michel
    Brentjens, Renier J.
    Hohl, Tobias M.
    Seo, Susan K.
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (04) : 533 - 540
  • [4] LONG-TERM DURABLE RESPONSES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (RJR) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), AND FOLLICULAR LYMPHOMA (FL) TREATED WITH TISAGENLECLEUCEL (TISA-CEL) AND ITS ASSOCIATION WITH PERSISTENCE OF CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS
    Awasthi, R.
    Waldron, E.
    Grupp, S. A.
    Pulsipher, M. A.
    Bader, P.
    Schuster, S. J.
    Maziarz, R.
    Waller, E.
    Jager, U.
    Thieblemont, C.
    Dreyling, M.
    Fowler, N.
    Maier, H. J.
    Willert, J.
    CYTOTHERAPY, 2024, 26 (06) : S152 - S152
1